Detalles de la búsqueda
1.
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models.
Breast Cancer Res;
23(1): 29, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663585
2.
Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors.
Eur J Immunol;
49(12): 2245-2251, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31532833
3.
Early-stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrence.
Acta Obstet Gynecol Scand;
99(2): 196-203, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562818
4.
Multifractal-based nuclei segmentation in fish images.
Biomed Microdevices;
19(3): 67, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28776236
5.
Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
Ann Surg Oncol;
23(7): 2242-8, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26965699
6.
High tumor budding stratifies breast cancer with metastatic properties.
Breast Cancer Res Treat;
150(2): 363-71, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25779101
7.
Androgen receptor status is highly conserved during tumor progression of breast cancer.
BMC Cancer;
15: 872, 2015 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26552477
8.
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.
Proc Natl Acad Sci U S A;
108(47): 18879-86, 2011 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22011582
9.
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.
BMC Cancer;
12: 134, 2012 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22471961
10.
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations.
Sci Rep;
12(1): 1248, 2022 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35075200
11.
Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology.
BMC Womens Health;
11: 44, 2011 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21961708
12.
Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.
Oncogene;
40(26): 4425-4439, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34108622
13.
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer.
Cancer Res;
81(21): 5572-5581, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518211
14.
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens.
J Immunother Precis Oncol;
4(2): 45-52, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35663531
15.
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors.
J Immunother Cancer;
8(1)2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303619
16.
Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.
Neuro Oncol;
22(1): 70-83, 2020 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31433055
17.
Phase 2 study of pembrolizumab in patients with advanced rare cancers.
J Immunother Cancer;
8(1)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32188704
18.
TAK228 enhances antitumor activity of eribulin in triple negative breast cancer.
Oncotarget;
10(49): 5011-5019, 2019 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31489111
19.
Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor.
Nat Commun;
10(1): 1398, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30923315
20.
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma.
J Immunother Cancer;
7(1): 253, 2019 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533818